Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v4-FR
Language French French
Date Updated 2024-08-08 2024-07-04
Drug Identification Number 02377705 02377705
Brand name TEVA-ERLOTINIB TEVA-ERLOTINIB
Common or Proper name ERLOTINIB HCL 100MG ERLOTINIB HCL 100MG
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ERLOTINIB ERLOTINIB
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size PP 30 PP 30
ATC code L01EB L01EB
ATC description
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-06-06 2024-06-06
Estimated end date 2024-08-10 2024-08-10
Actual end date 2024-08-07
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments